Raymond James & Associates Illumina, Inc. Transaction History
Raymond James & Associates
- $161 Billion
- Q3 2024
A detailed history of Raymond James & Associates transactions in Illumina, Inc. stock. As of the latest transaction made, Raymond James & Associates holds 441,182 shares of ILMN stock, worth $39.2 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
441,182
Previous 316,109
39.57%
Holding current value
$39.2 Million
Previous $33 Million
74.36%
% of portfolio
0.04%
Previous 0.02%
Shares
30 transactions
Others Institutions Holding ILMN
# of Institutions
968Shares Held
151MCall Options Held
2.37MPut Options Held
1.41M-
Black Rock Inc. New York, NY18.1MShares$1.6 Billion0.04% of portfolio
-
Capital World Investors Los Angeles, CA18MShares$1.6 Billion0.38% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.8MShares$1.4 Billion0.04% of portfolio
-
State Street Corp Boston, MA5.79MShares$514 Million0.03% of portfolio
-
Loomis Sayles & CO L P4.21MShares$374 Million0.71% of portfolio
About ILLUMINA, INC.
- Ticker ILMN
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 157,300,000
- Market Cap $14B
- Description
- Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....